SYNDEIO BIOSCIENCES
Live / Allowed — First extension granted (statement of use) (as of 31 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 30 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99210867
- Mark type
- Word mark
- Filed
- 30 May 2025
- Published for opposition
- 09 Dec 2025
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and therapeutics in the nature of bio-pharmaceutical preparations for the treatment of diseases and disorders affecting the brain and nervous system
- Class 042 — Scientific and technological services: Research and development in the field of neuroscience; drug discovery services in the field of neuroscience; providing scientific research information in the field of neuroscience
Owner
- Syndeio Biosciences, Inc., Indianapolis, IN, US
- Syndeio Biosciences, Inc., Indianapolis, IN, US
Prosecution history
- 31 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Jul 2026 — SOU EXTENSION 1 GRANTED
- 31 Jul 2026 — SOU EXTENSION 1 FILED
- 31 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Dec 2025 — PUBLISHED FOR OPPOSITION
- 03 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Oct 2025 — NON-FINAL ACTION E-MAILED
- 20 Oct 2025 — NON-FINAL ACTION WRITTEN